Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Other Liabilities
Prestige Consumer Healthcare Inc
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Other Liabilities
$15.1m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
48%
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Liabilities
$25B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Liabilities
$6.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
Pfizer Inc
NYSE:PFE
|
Other Liabilities
$27.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Liabilities
$8.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Liabilities
$7.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is Prestige Consumer Healthcare Inc's Other Liabilities?
Other Liabilities
15.1m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Other Liabilities amounts to 15.1m USD.
What is Prestige Consumer Healthcare Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
48%
Over the last year, the Other Liabilities growth was -26%. The average annual Other Liabilities growth rates for Prestige Consumer Healthcare Inc have been -27% over the past three years , -6% over the past five years , and 48% over the past ten years .